Accessibility Help | Sitemap | Contact Us | Customer Support CALL 1-800-275-4524
United States Change Country
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education / Training  |  For Patients  |  Customer Support  |  Suppliers
You are here: Home
Print

News & Media

These press releases are intended as reference information for U.S. investors and journalists. The information contained in each press release was current at the time of issuance, and KCI assumes no responsibility for updating the information to reflect subsequent developments.

Top Stories

KCI, Leader in Advanced Wound Care Solutions Independent Study Shows V.A.C. VeraFlo™ Therapy More Beneficial Than Traditional V.A.C.® Therapy

Study Found Statistically Significant Reductions in OR Visits and Hospital Stay vs. Traditional V.A.C.® Therapy

KCI, Leader in Advanced Wound Care Solutions LifeCell Corporation Acquires Advanced Adipose Tissue Injector

Injector Offers Added Benefits to Surgeons and Patients and Expands the LifeCell Fat Grafting Portfolio

Headlines

Displaying 1 to 10 of 144 News Items
January 23rd 2014
KCI Earns New Innovative Technology Designation from Novation® for V.A.C.Ulta™ Therapy and Prevena™ Therapy

Significant designation only provided to a small portion of products on contract through Novation

January 14th 2014
KCI Negative Pressure Wound Therapy with Instillation Supplement Published in International Wound Journal

Supplement Based on Presentations from the 2012 and 2013 International Surgical Wound Forums

January 8th 2014
First International Consensus Guidelines Published for KCI Negative Pressure Wound Therapy with Instillation

Guidelines Published in Journal of Plastic and Reconstructive Surgery

November 21st 2013
KCI Introduces the Next Generation V.A.C.Via™ Therapy System

Portable System Provides Enhanced Features for Patients

November 11th 2013
Growing Body of Evidence Supports V.A.C. VeraFlo™ Therapy Changing How Clinicians Approach Treating Wounds

Data Demonstrate Clinical and Economic Advantages of V.A.C. VeraFlo™ Therapy Compared to Traditional NPWT

October 28th 2013
KCI Completes Acquisition of Systagenix

Peter Huntley Appointed Senior Vice President and Leader of Systagenix

August 26th 2013
ABThera™ Open Abdomen Negative Pressure Therapy System Study Published in World Journal of Surgery

Significantly Improved Patient Outcomes Using ABThera™ Negative Pressure Therapy System in Open Abdomen Surgery

August 12th 2013
KCI Introduces New V.A.C. VeraFlo™ Large Dressing

Taking Away the Large Burden of Wound Healing

July 30th 2013
KCI to Acquire Systagenix

Strategic Transaction Strengthens KCI Leadership Position in Global Wound Care Market While Adding Diversification

Enhances Access to $3.4 Billion Advanced Wound Care Market, Leveraging KCI’s Well-Established Customer Relationships, Brand and Commercial Scale

Complementary Product Portfolio Will Advance Provision of Best-in-Class Solutions to Healthcare Professionals and Patients
 

Displaying 1 to 10 of 144 News Items

  • KCI Express
  • Share on Facebook.com
  • Share on Twitter
  • Visit our YouTube page